256 related articles for article (PubMed ID: 31296852)
21. MALT1 activation by TRAF6 needs neither BCL10 nor CARD11.
Bardet M; Seeholzer T; Unterreiner A; Woods S; Krappmann D; Bornancin F
Biochem Biophys Res Commun; 2018 Nov; 506(1):48-52. PubMed ID: 30336982
[TBL] [Abstract][Full Text] [Related]
22. Germline CBM-opathies: From immunodeficiency to atopy.
Lu HY; Biggs CM; Blanchard-Rohner G; Fung SY; Sharma M; Turvey SE
J Allergy Clin Immunol; 2019 May; 143(5):1661-1673. PubMed ID: 31060714
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms of Regulated and Dysregulated CARD11 Signaling in Adaptive Immunity and Disease.
Bedsaul JR; Carter NM; Deibel KE; Hutcherson SM; Jones TA; Wang Z; Yang C; Yang YK; Pomerantz JL
Front Immunol; 2018; 9():2105. PubMed ID: 30283447
[TBL] [Abstract][Full Text] [Related]
24. Ubiquitination and phosphorylation of the CARD11-BCL10-MALT1 signalosome in T cells.
Lork M; Staal J; Beyaert R
Cell Immunol; 2019 Jun; 340():103877. PubMed ID: 30514565
[TBL] [Abstract][Full Text] [Related]
25. CARD11 signaling in regulatory T cell development and function.
Carter NM; Pomerantz JL
Adv Biol Regul; 2022 May; 84():100890. PubMed ID: 35255409
[TBL] [Abstract][Full Text] [Related]
26. BCL10 Mutations Define Distinct Dependencies Guiding Precision Therapy for DLBCL.
Xia M; David L; Teater M; Gutierrez J; Wang X; Meydan C; Lytle A; Slack GW; Scott DW; Morin RD; Onder O; Elenitoba-Johnson KSJ; Zamponi N; Cerchietti L; Lu T; Philippar U; Fontan L; Wu H; Melnick AM
Cancer Discov; 2022 Aug; 12(8):1922-1941. PubMed ID: 35658124
[TBL] [Abstract][Full Text] [Related]
27. Clinical and Genetic Heterogeneity of
Israel L; Mellett M
Front Immunol; 2018; 9():2239. PubMed ID: 30386326
[TBL] [Abstract][Full Text] [Related]
28. Oncogenic CARD11 mutations in human diffuse large B cell lymphoma.
Lenz G; Davis RE; Ngo VN; Lam L; George TC; Wright GW; Dave SS; Zhao H; Xu W; Rosenwald A; Ott G; Muller-Hermelink HK; Gascoyne RD; Connors JM; Rimsza LM; Campo E; Jaffe ES; Delabie J; Smeland EB; Fisher RI; Chan WC; Staudt LM
Science; 2008 Mar; 319(5870):1676-9. PubMed ID: 18323416
[TBL] [Abstract][Full Text] [Related]
29. Combined immunodeficiency and atopy caused by a dominant negative mutation in caspase activation and recruitment domain family member 11 (CARD11).
Dadi H; Jones TA; Merico D; Sharfe N; Ovadia A; Schejter Y; Reid B; Sun M; Vong L; Atkinson A; Lavi S; Pomerantz JL; Roifman CM
J Allergy Clin Immunol; 2018 May; 141(5):1818-1830.e2. PubMed ID: 28826773
[TBL] [Abstract][Full Text] [Related]
30. The role of the CBM complex in allergic inflammation and disease.
DeVore SB; Khurana Hershey GK
J Allergy Clin Immunol; 2022 Nov; 150(5):1011-1030. PubMed ID: 35981904
[TBL] [Abstract][Full Text] [Related]
31. The CBM complex: A growing multiplicity of cellular functions, regulatory mechanisms and connections to human disease.
Schaefer BC
Cell Immunol; 2020 Oct; 356():104189. PubMed ID: 32771677
[No Abstract] [Full Text] [Related]
32. Overexpression of caspase recruitment domain (CARD) membrane-associated guanylate kinase 1 (CARMA1) and CARD9 in primary gastric B-cell lymphoma.
Nakamura S; Nakamura S; Matsumoto T; Yada S; Hirahashi M; Suekane H; Yao T; Goda K; Iida M
Cancer; 2005 Nov; 104(9):1885-93. PubMed ID: 16177990
[TBL] [Abstract][Full Text] [Related]
33. CARD9 versus CARMA1 in innate and adaptive immunity.
Hara H; Saito T
Trends Immunol; 2009 May; 30(5):234-42. PubMed ID: 19359218
[TBL] [Abstract][Full Text] [Related]
34. Zinc rescues obesity-induced cardiac hypertrophy via stimulating metallothionein to suppress oxidative stress-activated BCL10/CARD9/p38 MAPK pathway.
Wang S; Gu J; Xu Z; Zhang Z; Bai T; Xu J; Cai J; Barnes G; Liu QJ; Freedman JH; Wang Y; Liu Q; Zheng Y; Cai L
J Cell Mol Med; 2017 Jun; 21(6):1182-1192. PubMed ID: 28158919
[TBL] [Abstract][Full Text] [Related]
35. CARD11 mediates factor-specific activation of NF-kappaB by the T cell receptor complex.
Pomerantz JL; Denny EM; Baltimore D
EMBO J; 2002 Oct; 21(19):5184-94. PubMed ID: 12356734
[TBL] [Abstract][Full Text] [Related]
36. Deficiency of caspase recruitment domain family, member 11 (CARD11), causes profound combined immunodeficiency in human subjects.
Stepensky P; Keller B; Buchta M; Kienzler AK; Elpeleg O; Somech R; Cohen S; Shachar I; Miosge LA; Schlesier M; Fuchs I; Enders A; Eibel H; Grimbacher B; Warnatz K
J Allergy Clin Immunol; 2013 Feb; 131(2):477-85.e1. PubMed ID: 23374270
[TBL] [Abstract][Full Text] [Related]
37. Oncogenic CARMA1 couples NF-κB and β-catenin signaling in diffuse large B-cell lymphomas.
Bognar MK; Vincendeau M; Erdmann T; Seeholzer T; Grau M; Linnemann JR; Ruland J; Scheel CH; Lenz P; Ott G; Lenz G; Hauck SM; Krappmann D
Oncogene; 2016 Aug; 35(32):4269-81. PubMed ID: 26776161
[TBL] [Abstract][Full Text] [Related]
38. Cell type-specific regulation of ITAM-mediated NF-kappaB activation by the adaptors, CARMA1 and CARD9.
Hara H; Ishihara C; Takeuchi A; Xue L; Morris SW; Penninger JM; Yoshida H; Saito T
J Immunol; 2008 Jul; 181(2):918-30. PubMed ID: 18606643
[TBL] [Abstract][Full Text] [Related]
39. Human lymphoma mutations reveal CARD11 as the switch between self-antigen-induced B cell death or proliferation and autoantibody production.
Jeelall YS; Wang JQ; Law HD; Domaschenz H; Fung HK; Kallies A; Nutt SL; Goodnow CC; Horikawa K
J Exp Med; 2012 Oct; 209(11):1907-17. PubMed ID: 23027925
[TBL] [Abstract][Full Text] [Related]
40. Negative Regulation of CARD11 Signaling and Lymphoma Cell Survival by the E3 Ubiquitin Ligase RNF181.
Pedersen SM; Chan W; Jattani RP; Mackie dS; Pomerantz JL
Mol Cell Biol; 2015 Dec; 36(5):794-808. PubMed ID: 26711259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
